Intracerebral hemorrhage (ICH) is a severe
stroke subtype with high disability and mortality, and no effective treatment is available. Previous research on
intracerebral hemorrhage secondary
brain injury drugs mainly targeted at cell apoptosis,
inflammation and oxidative stress, but did not achieve good effects. In recent years, ferroptosis has become a focus concern in neurological diseases. Ferroptosis is a new type of programmed cell death caused by
iron-dependent accumulation of
lipid peroxides, in which
glutathione peroxidase 4 (GPX4) is a key
protein affecting ferroptosis. In this study, we used the STRING protein database to predict the
proteins that may be co-expressed with GPX4, and studied the ability of
Dauricine(Dau) to up-regulate the expression of GPX4 against ferroptosis and neuroprotection after
intracerebral hemorrhage in normal cells in vitro,
glutathione peroxidase 4 (GPX4) knockdown cells and
collagenase injection in vivo in mouse models of
intracerebral hemorrhage. The results showed that
glutathione reductase (GSR) was a possible co-expression
protein with GPX4. Dau could up-regulate the expression of
glutathione peroxidase 4 (GPX4) in
intracerebral hemorrhage(ICH) model, normal cells and GPX4 knockdown cells in vitro, and simultaneously up-regulate the expression of GSR in ICH mice. Dau could also reduce the levels of
iron and lipid peroxidation, and have a
neuroprotective effect on
intracerebral hemorrhage(ICH) mice. It was tesified that
Dauricine(Dau) could inhibit ferroptosis of nerve cells and alleviate
brain injury after
intracerebral hemorrhage by upregulating
glutathione peroxidase 4 (GPX4) and
glutathione reductase (GSR) co-expression. Therefore, Dau may be an effective drug for inhibiting ferroptosis and treating
intracerebral hemorrhage.